López-Sanromán, A., Vera-Mendoza, I., Domènech, E., Taxonera, C., Ruiz, V., Marín-Jiménez, I., . . . Nos, P. (2017). Adalimumab vs Azathioprine in the Prevention of Postoperative Crohn's Disease Recurrence. A GETECCU Randomised Trial.
Citación estilo ChicagoLópez-Sanromán, A., et al. Adalimumab Vs Azathioprine in the Prevention of Postoperative Crohn's Disease Recurrence. A GETECCU Randomised Trial. 2017.
Cita MLALópez-Sanromán, A., et al. Adalimumab Vs Azathioprine in the Prevention of Postoperative Crohn's Disease Recurrence. A GETECCU Randomised Trial. 2017.
Precaución: Estas citas no son 100% exactas.